Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion type Assertion NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_head.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion description "[To compare the impacts of electroacu puncture (EA) and moxibustion (Mox) on the prima ry gastrointestinal symptoms and the expressions of colonic mucosa-associated neuropeptide substance P (SP) and vasoactive intestinal peptide (VIP) in patients with either diarrhea-predominant or constipation-predominant irritable bowel syndrome (IBS-D and IBS-C, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion evidence source_evidence_literature NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion SIO_000772 26427109 NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion wasDerivedFrom befree-2016 NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.
- NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_assertion wasGeneratedBy ECO_0000203 NP1294608.RAG9adYWFkoYK-w6BC98B-5jm8I7vfgSYg9fC9KAEamPE130_provenance.